H2.0-Like Homeobox (HLX) (Middle Region) Peptide
HLX
Reactivity: Human
Host: Synthetic
BP, WB
Quick Overview for H2.0-Like Homeobox (HLX) (Middle Region) Peptide (ABIN978034)
Target
HLX
(H2.0-Like Homeobox (HLX))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- WFQNRRMKWR HSKEAQAQKD KDKEAGEKPS GGAPAADGEQ DERSPSRSEG
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-HLX Antibody(ARP58016_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- HLX (H2.0-Like Homeobox (HLX))
-
Background
-
HLX is a transcription factor required for TBX21/T-bet-dependent maturation of Th1 cells as well as maintenance of Th1-specific gene expression. Involved in embryogenesis and hematopoiesis.
Alias Symbols: HB24, HLX1
Protein Size: 488 -
Molecular Weight
- 51 kDa
-
Gene ID
- 3142
-
NCBI Accession
- NM_021958, NP_068777
-
UniProt
- Q14774
Target
-
You are here:
